Search
Now showing items 1-4 of 4
Antithrombotic in atrial fibrillation and coronary artery disease – Does less mean more?
(2022-06-15)
In the treatment of patients with chronic coronary syndrome, the use of antiplatelets in the form of aspirin is a class 1 indication in the prevention of future thrombotic events.1 Similarly, oral anticoagulation (OAC) has ...
Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: An European and Asia-Pacific Expert Consensus Paper
(2022-03-22)
Whilst there is a clear clinical benefit of oral anticoagulation (OAC) in patients with atrial fibrillation (AF) and venous thromboembolism (VTE) in reducing the risks of thromboembolism, major bleeding events (especially ...
Assessment of endogenous fibrinolysis in clinical using novel tests - Ready for clinical roll-out?
(2021-04-01)
The occurrence of thrombotic complications, which can result in excess mortality and morbidity, represent an imbalance between the pro-thrombotic and fibrinolytic equilibrium.The mainstay treatment of these complications ...
Usefulness of the NULL-PLEASE Score to predict 1 survival in out-of hospital cardiac arrest
(2020-05-07)
Purpose: Out-of-hospital cardiac arrest (OHCA) carries a very high mortality even after successful cardiopulmonary resuscitation. Currently, information given to relatives regarding prognosis following resuscitation is ...